699 related articles for article (PubMed ID: 16684322)
21. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.
Renshaw AA; Derhagopian RP; Martinez P; Gould EW
Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208
[TBL] [Abstract][Full Text] [Related]
22. Papillary lesions of the breast diagnosed by core needle biopsy: 71 cases with surgical follow-up.
Bernik SF; Troob S; Ying BL; Simpson SA; Axelrod DM; Siegel B; Moncrief RM; Mills C; Aziz M
Am J Surg; 2009 Apr; 197(4):473-8. PubMed ID: 18723154
[TBL] [Abstract][Full Text] [Related]
23. [Histopathology of the breast with reference to consultant studies. II. On the diagnosis and differential diagnosis of non-neoplastic diseases and tumors].
Bässler R; Kronsbein H; Schneider B
Pathologe; 1989 May; 10(3):142-59. PubMed ID: 2544866
[No Abstract] [Full Text] [Related]
24. Pathological criteria and practical issues in papillary lesions of the breast - a review.
Ni YB; Tse GM
Histopathology; 2016 Jan; 68(1):22-32. PubMed ID: 26768027
[TBL] [Abstract][Full Text] [Related]
25. [The so-called minimal cancers of the breast (author's transl)].
Andry G; Mendes da Costa PW; Vandenheule B; Mattheiem W
Acta Chir Belg; 1977; 76(4):453-6. PubMed ID: 200040
[TBL] [Abstract][Full Text] [Related]
26. [Histopathological diagnosis of papillary lesion of the breast].
Akiyama F; Sakamoto G
Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():32-5. PubMed ID: 7747989
[TBL] [Abstract][Full Text] [Related]
27. Intraductal proliferations of the breast: a review of histologic criteria for atypical intraductal hyperplasia and ductal carcinoma in situ, including apocrine and papillary lesions.
Purcell CA; Norris HJ
Ann Diagn Pathol; 1998 Apr; 2(2):135-45. PubMed ID: 9845731
[TBL] [Abstract][Full Text] [Related]
28. Cytokeratin 5 and estrogen receptor immunohistochemistry as a useful adjunct in identifying atypical papillary lesions on breast needle core biopsy.
Grin A; O'Malley FP; Mulligan AM
Am J Surg Pathol; 2009 Nov; 33(11):1615-23. PubMed ID: 19675450
[TBL] [Abstract][Full Text] [Related]
29. Papillary carcinoma-in-situ of the breast presenting as a fungating lesion.
Chisholm LJ; Gupta R; Theaker JM; Royle GT
Eur J Surg Oncol; 2000 Aug; 26(5):517-8. PubMed ID: 11016476
[TBL] [Abstract][Full Text] [Related]
30. Needle tract seeding after vacuum-assisted breast biopsy.
Michalopoulos NV; Zagouri F; Sergentanis TN; Pararas N; Koulocheri D; Nonni A; Filippakis GM; Chatzipantelis P; Bramis J; Zografos GC
Acta Radiol; 2008 Apr; 49(3):267-70. PubMed ID: 18365811
[TBL] [Abstract][Full Text] [Related]
31. Targeting difficult accessible breast lesions: MRI-guided needle localization using a freehand technique in a 3.0 T closed bore magnet.
Meeuwis C; Peters NH; Mali WP; Gallardo AM; van Hillegersberg R; Schipper ME; van den Bosch MA
Eur J Radiol; 2007 May; 62(2):283-8. PubMed ID: 17218074
[TBL] [Abstract][Full Text] [Related]
32. Carcinoma within solitary ductal papilloma of the breast.
Greif F; Sharon E; Shechtman I; Morgenstern S; Gutman H
Eur J Surg Oncol; 2010 Apr; 36(4):384-6. PubMed ID: 19646841
[TBL] [Abstract][Full Text] [Related]
33. Precancerous lesions of the breast.
Costa A; Zanini V
Nat Clin Pract Oncol; 2008 Dec; 5(12):700-4. PubMed ID: 18825141
[TBL] [Abstract][Full Text] [Related]
34. Validity of needle core biopsy in the histological characterisation of mammary lesions.
Cipolla C; Fricano S; Vieni S; Amato C; Napoli L; Graceffa G; Latteri S; Latteri MA
Breast; 2006 Feb; 15(1):76-80. PubMed ID: 16473738
[TBL] [Abstract][Full Text] [Related]
35. Accuracy of needle core biopsies in the diagnosis of papillary breast lesions.
Sahasrabudhe N; Beetles U; Coyne J
Histopathology; 2006 Jul; 49(1):91. PubMed ID: 16842253
[No Abstract] [Full Text] [Related]
36. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms.
Raju UB; Lee MW; Zarbo RJ; Crissman JD
Mod Pathol; 1989 Nov; 2(6):569-76. PubMed ID: 2479944
[TBL] [Abstract][Full Text] [Related]
37. Double immunostaining with p63 and high-molecular-weight cytokeratins distinguishes borderline papillary lesions of the breast.
Ichihara S; Fujimoto T; Hashimoto K; Moritani S; Hasegawa M; Yokoi T
Pathol Int; 2007 Mar; 57(3):126-32. PubMed ID: 17295644
[TBL] [Abstract][Full Text] [Related]
38. [Pathological findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ)].
Haase W
Strahlenther Onkol; 1996 Feb; 172(2):109-10. PubMed ID: 8669043
[No Abstract] [Full Text] [Related]
39. Are encapsulated papillary carcinomas of the breast in situ or invasive? A basement membrane study of 27 cases.
Esposito NN; Dabbs DJ; Bhargava R
Am J Clin Pathol; 2009 Feb; 131(2):228-42. PubMed ID: 19141383
[TBL] [Abstract][Full Text] [Related]
40. Intraductal papillomas on core biopsy can be upgraded to malignancy on subsequent excisional biopsy regardless of the presence of atypical features.
Shiino S; Tsuda H; Yoshida M; Jimbo K; Asaga S; Hojo T; Kinoshita T
Pathol Int; 2015 Jun; 65(6):293-300. PubMed ID: 25801805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
